Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
HEM Research |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002269 |
To evaluate ampligen at two dosage levels given twice weekly in combination with zidovudine (AZT) versus AZT alone in individuals with HIV-related immune dysfunction defined as T4 count between 100 and 300 cells/mm3.
Condition | Intervention |
---|---|
HIV Infections |
Drug: Ampligen Drug: Zidovudine |
Study Type: | Interventional |
Study Design: | Treatment, Double-Blind |
Official Title: | A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
Concurrent Medication:
Excluded:
Patients with the following are excluded:
Required:
Required at least 6 months prior to study entry:
Active drug abuse.
United States, Florida | |
Miami Veterans Administration Med Ctr | |
Miami, Florida, United States, 33125 | |
United States, Oregon | |
Oregon Health Sciences Univ | |
Portland, Oregon, United States, 97201 | |
United States, Pennsylvania | |
MCP Hahnemann Univ Hosp | |
Philadelphia, Pennsylvania, United States, 19102 | |
United States, Texas | |
Nelson Tebedo Community Clinic | |
Dallas, Texas, United States, 75219 | |
Dr Patricia Salvato | |
Houston, Texas, United States, 77054 |
Study ID Numbers: | 073A, AMP-700 |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002269 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Acquired Immunodeficiency Syndrome ampligen AIDS-Related Complex Zidovudine |
Antimetabolites Sexually Transmitted Diseases, Viral Anti-HIV Agents Acquired Immunodeficiency Syndrome Zidovudine AIDS-Related Complex Antiviral Agents Immunologic Deficiency Syndromes |
Ampligen Reverse Transcriptase Inhibitors Virus Diseases Anti-Retroviral Agents HIV Infections Sexually Transmitted Diseases Retroviridae Infections |
Antimetabolites Anti-Infective Agents Sexually Transmitted Diseases, Viral Slow Virus Diseases Molecular Mechanisms of Pharmacological Action Zidovudine Infection Reverse Transcriptase Inhibitors Anti-Retroviral Agents Therapeutic Uses Retroviridae Infections Nucleic Acid Synthesis Inhibitors RNA Virus Infections |
Anti-HIV Agents Immune System Diseases Acquired Immunodeficiency Syndrome Enzyme Inhibitors Antiviral Agents Immunologic Deficiency Syndromes Pharmacologic Actions Ampligen Virus Diseases HIV Infections Sexually Transmitted Diseases Lentivirus Infections |